Back to Agenda
Session 1: Part 1
Session Chair(s)
Isabelle C. Widmer, DrMed
CEO elytra GmbH, Consultant
elytra GmbH, Switzerland
Agility in the face of a global pandemic – creative Medical Information solutions and collaboration across teams to provide customers with tailored support The pharmaceutical industry operates in a fast-paced environment. However, nothing could have prepared any of us for 2020. This is a year of firsts. Including this first virtual EU DIA Medical Information and Communications conference. The Romans said - times change, and we change with them. What fascinates me is how fast our world changed this year and how fast we adapted. At home. At work. Socially. We are now used to closed borders. Grounded flights. Working from home. Social distancing. News about toilet paper stockpiling. Curfews. Being locked down. Happy hour via Zoom. Dancing in our living rooms. And face masks. In the first session of the conference we will share how Medical Information teams adapted to this new reality. Paola Amore, Novartis Italy will share the many creative ways her team supported HCPs and patients, in a country where hospitals struggled to manage patients affected by COVID-19. Sebastián Rodríguez Sánchez, Gilead, Europe, will share how a company with a treatment for COVID-19 built the capabilities to manage customer needs. After the presentations we will discuss key success factors for adapting to an unprecedented situation, such as the pandemic, and have an extended Q and A session.
Learning Objective : 1) Understand key approaches to supporting customers during the pandemic 2) Identify what can be put in place as a foundation to manage the challenges depending on the current set-up of one’s own organization 3) know potentially relevant platforms and tools, as well as how to collaborate across an organization to support efficient scaling up of efforts
Speaker(s)
External and internal collaborations for best medical information service delivery
Paola Amore
Novartis, Italy
Medical Education & Digital Manager
Dealing with a pandemic when you have a potential treatment for COVID-19
Sebastian Rodriguez Sanchez, MPharm
Gilead Sciences Europe, United Kingdom
Director, Global Medical Information ACE Region Head
Have an account?